Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades10,774
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions1
GSK
Media1
GSK Company
Research
GSK Company
Timeline3
Share Price Information for Glaxosmithkline (GSK)
Last checked at -
Last checked at 
Intraday Glaxosmithkline Share Chart
Glaxosmithkline News
LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence
(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.
Zantac ruling throws a "significant spanner into the works" for GSK
(Alliance News) - An adverse US court ruling regarding GSK PLC's heartburn drug, Zantac, was a "surprise," and will, in the short-term, pour "more unc...
TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac
(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn d...
LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs
(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several o...
LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim
(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing mana...
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases broug...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert ...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert ...
Follow the stocks
